ANTX
#3591
AN2 Therapeutics, Inc. - Common Stock
5.5 8 USD
-0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.79%
Variación mensual
+10.93%
Variación en los últimos 6 meses
+407.27%
Cambio anual
+398.21%
Cierres anteriores
5.7 4
Open
5.5 8
Mínimo
5.5 8
Máximo
5.5 8
Volumen
15
Financials
- Market Capitalization 210.57 M
- Employee 21
- Founded 2017
- CEO N/A
- Website www.an2therapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00QYLYBK4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3588 |  ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 2.92 USD | -3.63% | -7.89% | +37.74% | +116.30% | 211.17 M USD | ||
| 3590 |  CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | 10.91 USD | -1.98% | +6.96% | +20.15% | -34.28% | 211.01 M USD | ||
| 3592 |  IMUX Immunic, Inc. - Common Stock | 15.40 USD | -5.52% | -6.55% | +18.46% | +1778.05% | 210.12 M USD | ||
| 3593 |  ORMP Oramed Pharmaceuticals Inc. - Common Stock | 5.03 USD | -1.37% | +4.57% | +20.33% | +129.68% | 209.23 M USD |